Register now!

The Avicenna Alliance itself has its origins in the Avicenna Roadmap, a 2-year EU funded project, led by DG Connect whose goal was to create a research and technological development Roadmap outlining a strategy for in silico Clinical Trials (ISCT).

 Built into the European Commission’s project requirements was a plan to establish a pre-competitive Association – the Avicenna Alliance, that would represent the needs of the in silico medicine community and provide the Commission and other policy makers with expert advice in this field.

The Avicenna Alliance operating since 2016, now works with members to implement this Roadmap and identify policy and regulatory obstacles to the enhancement of in silico medicine.

The Avicenna Alliance is a researcher and industry partnership with 50% membership of the Virtual Physiological Human Initiative (VPH) and 50% representation of the medical devices, pharmaceuticals, software and cosmetics industries.

By engaging both researchers and industry in the conversation on how to roll out this roadmap, the Avicenna Alliance is the one stop shop for all things in silico medicine at EU level.

To find out if you could benefit from Membership of the Avicenna Alliance, click here.

The completed Avicenna Roadmap

Downloadable version (5,6 MB)

More information about the Avicenna Roadmap can be found here

Avicenna Alliance news

Avicenna Alliance – Review 2016

A look back at the year 2016 reveals that it has been a very successful first year for the Avicenna Alliance.

find out more ›

Professional Engineering magazine interviews Avicenna Alliance Secretary General

For its December 2016 issue, Professional Engineering, the magazine for the 110,000 members of the Institution of...

find out more ›

Maltese Presidency of the Council of the European Union published its official programme – relevant aspects for Avicenna Alliance

As part of the rotating Presidency of the Council of the European...

find out more ›

Show all activites